Key result
Epicardial 3830 lead implantation proves feasible in an 11-day-old neonate with complete AV block.
Why the study?
To evaluate the feasibility of using the 3830 lead for epicardial permanent pacing in pediatric patients.
Is permanent pacemaker implantation via an epicardial approach using the 3830 lead feasible in a neonate with complete third-degree AV block?
Is permanent pacemaker implantation via an epicardial approach using the 3830 lead feasible in a neonate with complete third-degree AV block?
This case report suggests the feasibility of using the 3830 lead for epicardial permanent pacemaker implantation in neonates with complete AV block.
Supports epicardial pacing feasibility in neonatal heart block; hypothesis-generating and requires validation before practice change.
This report summarizes the case of a neonate with neonatal lupus erythematosus (NLE) and complete third-degree atrioventricular block who underwent permanent pacemaker implantation via an epicardial approach. It focuses on the etiology, indications for intervention, and surgical procedure, and evaluates the feasibility of using the 3830 lead for epicardial permanent pacing in pediatric patients.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question. Epicardial permanent pacemaker implantation using the 3830 lead was feasible in an 11-day-old neonate with neonatal lupus erythematosus and complete third-degree AV block.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: